Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
6-Week Titration Phase	STARTED	Placebo	152
6-Week Titration Phase	STARTED	Retigabine	154
6-Week Titration Phase	COMPLETED	Placebo	138
6-Week Titration Phase	COMPLETED	Retigabine	125
6-Week Titration Phase	NOT COMPLETED	Placebo	14
6-Week Titration Phase	NOT COMPLETED	Retigabine	29
12-Week Maintenance Phase	STARTED	Placebo	138
12-Week Maintenance Phase	STARTED	Retigabine	125
12-Week Maintenance Phase	COMPLETED	Placebo	126
12-Week Maintenance Phase	COMPLETED	Retigabine	97
12-Week Maintenance Phase	NOT COMPLETED	Placebo	12
12-Week Maintenance Phase	NOT COMPLETED	Retigabine	28

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00232596/flow